In combination with the clonal expansion observed in the CD8 GZMB+ subtype upon GOLP therapy, these results support CD8 GZMB+ as a predive factor and therapeutic target worthy of further exploration in iCCA. Here, CD8A is linked to infantile convulsions and choreoathetosis.